Industry Verticals »

All Categories

Insights »

About TMR »

Cardiovascular Proximal Anastomosis Devices Market

Cardiovascular Proximal Anastomosis Devices Market (Product Type: Automatic Proximal Anastomotic Devices and Manual Proximal Anastomotic Devices; and End User: Hospitals, Ambulatory Surgical Centers, and Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Triage Classification System Gains Importance for Urgent Care During COVID-19 Crisis

The coronavirus has exposed the vulnerability of healthcare systems. Given the extensive perioperative and postoperative care procedures involving blood products, anesthesia staff, and ICU (Intensive Care Unit) care, healthcare advisors are suggesting a triage classification system. This classification can help to prioritize patients in need of urgent care, since healthcare facilities in many regions continue to be compromised. Such measures are reviving growth of the global cardiovascular proximal anastomosis devices market.

Patients undergoing cardiac surgery are a unique population in this COVID-19 epidemic, owing to the risk of exposure to highly invasive, aerosol?generating procedures (AGP), and prolonged hospitalization stay. Hence, manufacturers in the cardiovascular proximal anastomosis devices market are maintaining robust supply chains to meet the demands of clinicians.

Clampless Proximal Anastomosis Devices Help Overcome Challenges in Cardiac Surgery

The cardiovascular proximal anastomosis devices market is expected to reach US$ 23.6 Mn by 2030. However, it has been found that porcelain or shaggy ascending aortas are considered to be challenging in the cardiac surgery despite the availability of cardiopulmonary bypass and hybrid aortic arch debranching. Hence, healthcare companies are increasing awareness about clampless proximal anastomosis.

Companies in the cardiovascular proximal anastomosis devices market are increasing the availability of clampless proximal anastomosis devices meant for small aortic approaches. Surgeons are using this device to treat patients who previously underwent aortic surgery.

Safe Mechanism of Clampless Anastomosis Device Being Preferred in Operating Rooms

Manufacturers in the cardiovascular proximal anastomosis devices market are innovating in products that minimize aortic manipulation during on and off pump coronary artery bypass grafting (CABG). Vascular Graft Solutions - a company focused on improving the outcome of bypass surgery, has gained FDA (Food & Drug Administration) approval for its Viola clampless anastomosis device, which helps cardiac surgeons to perform protected, clean, and dry proximal anastomosis without partial clamping the aorta.

Reliable design and safe mechanism of clampless anastomosis device are being preferred by cardiac surgeons. Med-tech companies are boosting their R&D to create devices that address one of the biggest unmet needs in CABG, which is vein graft failure and perioperative neurological complications. Hence, companies are accommodating integrated punching mechanism and excellent sealing quality in clampless anastomosis devices to help perform multiple anastomosis with a single device.

Proximal Anastomotic Devices Acquire Popularity as Quick Solution for Saphenous Vein-Aortic Anastomosis

The cardiovascular proximal anastomosis devices market is slated to clock a favorable CAGR of ~6% during the assessment period. Off-pump coronary artery bypass grafting (OPCABG) is considered as the gold standard for cardiac surgeries and is most effective in minimally invasive surgeries to avoid injury of multiple organ malfunction caused by cardiopulmonary bypass. OPCABG has helped to reduce incidence of postoperative neurological complications caused by aortic intubation.

Proximal anastomotic devices are gaining popularity as a safe, simple, and quick solution for saphenous vein-aortic anastomosis. Med-tech companies in the cardiovascular proximal anastomosis devices market are benefitting from this, since these devices have paved the way for better outcomes in cardiac surgery.

Robotics Simplify Internal Mammary Artery Harvesting During Coronary Artery Bypass

Med-tech companies in the cardiovascular proximal anastomosis devices market are unlocking growth opportunities with robotic surgical systems. Since robotics is still in its early development stage for cardiac surgery, these systems are being used for minimally invasive technique in coronary bypass surgery. It has been found that robotic assistance simplifies internal mammary artery harvesting during robot-assisted direct coronary artery bypass by minimizing rip spreading.

Robotic surgical systems are enabling the meticulous manipulation of the internal mammary artery harvesting through visual magnification of the surgical field. Thus, robotics is translating into future incremental opportunities for companies in the cardiovascular proximal anastomosis devices market.

Analysts’ Viewpoint

The triage classification system helps to know a patient’s preoperative COVID-19 status, which may help in postoperative management and counseling, owing to high prevalence of asymptomatic coronavirus. Automated proximal anastomotic devices (APAD) are being publicized as non-invasive and innovative alternative for the creation of proximal anastomoses. However, it has been found that APAD does not entirely prevent the risk of neurological events and mortality. Hence, companies in the cardiovascular proximal anastomosis devices market should gain a strong research base for APAD and increase awareness about its advantages such as satisfactory one-year graft patency and low incidence of major adverse cardiovascular events.

Cardiovascular Proximal Anastomosis Devices Market: Overview

  • According to Transparency Market Research’s latest report on the global cardiovascular proximal anastomosis devices market for the historical year 2018 and forecast period 2020–2030, surge in prevalence of cardiovascular diseases and rise in technological advancements in treatment therapies are projected to drive the global cardiovascular proximal anastomosis devices market during the forecast period
  • According to the report, the global cardiovascular proximal anastomosis devices market was valued at US$ 12.9 Mn in 2019. It is anticipated to expand at a CAGR of 5.7% from 2020 to 2030.

Rise in Prevalence of Cancer: Key Driver

  • Smoking has also been identified as one of the causes of coronary heart disease across the globe. According to The Tobacco Atlas, about 5.7 trillion cigarettes were smoked worldwide in 2016, which is likely to reach between 6.7 trillion and 6.8 trillion by 2020.
  • Increase in the number of people adopting sedentary lifestyle, along with smoking and tobacco & alcohol consumption, and an unbalanced diet is anticipated to boost the cardiovascular proximal anastomosis devices market
  • According to the World Health Organization (WHO), cardiovascular diseases account for nearly 17.9 million deaths every year, which is estimated to be 31% of all global deaths. This makes cardiovascular diseases (CVDs) the leading cause of death around the world.
  • Coronary heart disease is a highly common type of heart disease, killing 365,914 people in 2017, which makes it a leading cause of death in the U.S.
  • According to CDC, 18.2 million adults aged 20 and older have CAD (about 6.7%) in the U.S. Of every 10 deaths, two occur from CAD in adults less than 65 years old. Rise in prevalence of coronary artery disease (CAD) is projected to fuel the global cardiovascular proximal anastomosis devices market during the forecast period.
  • Aging is a key factor responsible for hypertension and high cholesterol. This is likely to increase the prevalence of cardiovascular diseases in the elderly population.
  • According to the World Health Organization (WHO), population aged 60 years and above is projected to rise from 900 million in 2015 to 2000 million in 2050
  • Increase in geriatric population leads to a surge in incidence of age-related problems such as cardiovascular diseases, and also other conditions such as diabetes, high cholesterol, and hypertension, which leads to cardiovascular diseases

Technological Advancements in Treatment Therapies to Boost Market

  • Continuous technological developments in the cardiovascular devices segment with respect to higher efficiency and efficacy have widened the scope of device manufacturing
  • Technologically advanced anastomosis devices would eliminate major risks that occur during surgical procedures such as reducing aortic manipulation and consequently, the potential risk of neurological events
  • Benefits provided by these devices are that they require less operating time, offer convenience to surgeons, reduced exposure to anesthesia, and minimum probability of blood leaks
  • Industry players are extensively focusing on R&D to provide innovative solutions. For instance, MAQUET Cardiovascular, which is now subsidiary of Getinge AB, has developed Heartstring Proximal Seal System that facilitates hand suturing among aorta and coronary bypass channel without clamping, which results in lower risks of neurological complications and lower mortality.

High Cost of Anastomosis Devices and Availability of Alternative Treatments to Hamper Market

  • The cardiovascular proximal anastomosis devices market is technology driven. Introduction of new technologies in the market increases the demand for these devices due to improved efficiency and outcomes. However, high pricing of these new devices leads to affordability issues, which restrains the market, especially in developing regions.
  • Cardiovascular proximal anastomosis devices are witnessing less demand due to high cost in developing countries and lack of skilled/trained manpower
  • Unfavorable insurance coverage for cardiovascular devices results in less affordability among the patient population
  • Hence, high cost of cardiovascular proximal anastomosis devices is likely to hamper the market
  • Physicians and patients may select a variety of treatments to address coronary artery disease, with the selection often depending on the stage and severity of the disease and the age of the patient
  • In addition to changes in patient lifestyle, such as smoking cessation, weight reduction, diet changes, and exercise programs, the principal existing treatments for coronary artery disease include the following:
    • Percutaneous transluminal coronary angioplasty, commonly referred to as balloon angioplasty, is a surgical procedure that involves the dilation of the obstructed artery with a balloon catheter. During an angioplasty, the surgeon maneuvers a flexible balloon catheter to the site of the blockage in the coronary artery, inflates the balloon, compressing the plaque and stretching the artery wall to create a larger channel for blood flow.

Cardiovascular Proximal Anastomosis Devices Market: Competition Landscape

  • This report profiles major players in the global cardiovascular proximal anastomosis devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Leading players operating in the global cardiovascular proximal anastomosis devices market are
    • B. Braun Melsungen AG
    • Medtronic plc
    • Getinge AB
    • Péters Surgical

Cardiovascular Proximal Anastomosis Devices Market: Key Developments

  • Key players in the global cardiovascular proximal anastomosis devices market are engaged in regulatory approvals, development of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the global cardiovascular proximal anastomosis devices market over the next few years. Few expansion strategies adopted by players operating in the global cardiovascular proximal anastomosis devices market are:
    • In March 2019, Medtronic plc signed a definitive agreement to acquire EPIX Therapeutics, Inc., which engages in the design and manufacture of novel, catheter-based, temperature-controlled cardiac ablation system for the treatment of patients with cardiac arrhythmias
    • In November 2018, after three years of acquisition of stake in Gurgaon-based Stericat, Péters Surgical invested over EUR 5 Mn to expand its existing manufacturing facility in India
    • In October 2018, Atrium Medical Corporation, a subsidiary of Getinge AB, divested its biosurgery business to HJ Capital 1, the parent company of SeCQure Surgical Corporation
    • In February 2018, Aesculap announced the asset acquisition of Dextera Surgical, Inc. Dextera specializes in the design, manufacture, and marketing of proprietary medical devices for surgical procedures, including surgical staplers and innovative devices for coronary artery bypass graft (CABG) surgery.
    • In June 2013, Eurazeo PME acquired Péters Surgical, the world's fourth-largest surgical suture specialist, from UI Gestion, based on an enterprise value of approximately EUR 45 Mn. Eurazeo PME is expected to own nearly 90% of the share capital alongside senior management.
  • The report on the global cardiovascular proximal anastomosis devices market discussed individual strategies, followed by company profiles of treatment providers of cardiovascular proximal anastomosis devices. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global cardiovascular proximal anastomosis devices market.

Global Cardiovascular Proximal Anastomosis Devices Market - Segmentation

Product Type
  • Automatic Proximal Anastomotic Devices
  • Manual Proximal Anastomotic Devices
End-user
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
Region
  • U.S.
  • Europe
  • Middle East & Africa
  • Japan
  • Rest of World

Frequently Asked Questions

What is the total market worth of cardiovascular proximal anastomosis devices market?

Cardiovascular proximal anastomosis devices market is expected to reach US$ 23.6 Mn by 2030

What is the anticipated CAGR of the cardiovascular proximal anastomosis devices market in the forecast period?

Cardiovascular proximal anastomosis devices market is projected to expand at a CAGR of ~6% from 2020 to 2030

What are the key driving factors for the growth of the cardiovascular proximal anastomosis devices market?

Cardiovascular proximal anastomosis devices market is driven by rise in technological advancements in treatment therapies

Which is the rising prominent segment in the cardiovascular proximal anastomosis devices market?

The manual proximal anastomotic devices segment dominated the global cardiovascular proximal anastomosis devices market, and the trend is projected to continue during the forecast period

Who are the key players in the global cardiovascular proximal anastomosis devices market?

Key players in the global cardiovascular proximal anastomosis devices market include B. Braun Melsungen AG, Medtronic plc, Getinge AB, and Péters Surgical

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Cardiovascular Proximal Anastomosis Devices Market 

    4. Market Overview

        4.1. Overview

        4.2. Market Dynamics

            4.2.1. Drivers

            4.2.2. Restraints

            4.2.3. Opportunities

        4.3. Global Cardiovascular Proximal Anastomosis Devices Market Analysis and Forecast, 2018–2030

            4.3.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Epidemiology of Cardiovascular Diseases, by Country/Region

        5.2. Pricing and Volume Analysis, by Key Products/Brands 

        5.3. Key Industry Events

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Cardiovascular Proximal Anastomosis Devices Market Analysis and Forecast, by Product Type 

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Global Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by Product Type, 2018–2030

            6.3.1. Automatic Proximal Anastomotic Devices

            6.3.2. Manual Proximal Anastomotic Devices

        6.4. Market Attractiveness, by Product Type 

    7. Global Cardiovascular Proximal Anastomosis Devices Market Analysis and Forecast, by End-user 

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Global Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by End-user, 2018–2030

            7.3.1. Hospitals

            7.3.2. Ambulatory Surgical Centers

            7.3.3. Specialty Clinics

        7.4. Global Cardiovascular Proximal Anastomosis Devices Market Attractiveness, by End-user 

    8. Global Cardiovascular Proximal Anastomosis Devices Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2.  Global Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by Region

            8.2.1. U.S. 

            8.2.2. Europe 

            8.2.3. Middle East & Africa 

            8.2.4. Japan 

            8.2.5. Rest of World 

        8.3. Global Cardiovascular Proximal Anastomosis Devices Market Attractiveness, by Country/Region

    9. U.S. Cardiovascular Proximal Anastomosis Devices Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. U.S. Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by Product Type, 2018–2030

            9.2.1. Automatic Proximal Anastomotic Devices

            9.2.2. Manual Proximal Anastomotic Devices

        9.3. U.S. Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by End-user, 2018–2030

            9.3.1. Hospitals

            9.3.2. Ambulatory Surgical Centers

            9.3.3. Specialty Clinics

        9.4. U.S. Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis 

            9.4.1. By Product Type 

            9.4.2. By End-user 

    10. Europe Cardiovascular Proximal Anastomosis Devices Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by Product Type, 2018–2030

            10.2.1. Automatic Proximal Anastomotic Devices

            10.2.2. Manual Proximal Anastomotic Devices

        10.3. Europe Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by End-user, 2018–2030

            10.3.1. Hospitals

            10.3.2. Ambulatory Surgical Centers

            10.3.3. Specialty Clinics

        10.4. Europe Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by Country/Sub-region, 2018–2030

            10.4.1. Germany

            10.4.2. UK

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Europe Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis 

            10.5.1. By Product Type 

            10.5.2. By End-user 

            10.5.3. By Country/Sub-region

    11. Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by Product Type, 2018–2030

            11.2.1. Automatic Proximal Anastomotic Devices

            11.2.2. Manual Proximal Anastomotic Devices

        11.3. Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by End-user, 2018–2030

            11.3.1. Hospitals

            11.3.2. Ambulatory Surgical Centers

            11.3.3. Specialty Clinics

        11.4. Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by Country/Sub-region, 2018–2030

            11.4.1. GCC Countries

            11.4.2. South Africa

            11.4.3. Rest of Middle East & Africa

        11.5. Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis

            11.5.1. By Product Type

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Japan Cardiovascular Proximal Anastomosis Devices Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Japan Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by Product Type, 2018–2030

            12.2.1. Automatic Proximal Anastomotic Devices

            12.2.2. Manual Proximal Anastomotic Devices

        12.3. Japan Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by End-user, 2018–2030

            12.3.1. Hospitals

            12.3.2. Ambulatory Surgical Centers

            12.3.3. Specialty Clinics

        12.4. Japan Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis 

            12.4.1. By Product Type 

            12.4.2. By End-user 

    13. Rest of World Cardiovascular Proximal Anastomosis Devices Market  Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Rest of World Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by Product Type, 2018–2030

            13.2.1. Automatic Proximal Anastomotic Devices

            13.2.2. Manual Proximal Anastomotic Devices

        13.3. Rest of World Cardiovascular Proximal Anastomosis Devices Market Value & Volume Forecast, by End-user, 2018–2030

            13.3.1. Hospitals

            13.3.2. Ambulatory Surgical Centers

            13.3.3. Specialty Clinics

        13.4. Rest of World Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis

            13.4.1. By Product Type

            13.4.2. By End-user

    14. Competition Landscape

        14.1. Company Profiles

            14.1.1. B. Braun Melsungen AG

                14.1.1.1. Company Details

                14.1.1.2. Company Description

                14.1.1.3. Business Overview

                14.1.1.4. SWOT Analysis

                14.1.1.5. Strategic Overview

            14.1.2. Medtronic plc

                14.1.2.1. Company Details

                14.1.2.2. Company Description

                14.1.2.3. Business Overview

                14.1.2.4. SWOT Analysis

                14.1.2.5. Strategic Overview

            14.1.3. Getinge AB

                14.1.3.1. Company Details

                14.1.3.2. Company Description

                14.1.3.3. Business Overview

                14.1.3.4. SWOT Analysis

                14.1.3.5. Strategic Overview

            14.1.4. Péters Surgical 

                14.1.4.1. Company Details

                14.1.4.2. Company Description

                14.1.4.3. Business Overview

                14.1.4.4. SWOT Analysis

                14.1.4.5. Strategic Overview

            14.1.5. Abbott Laboratories

                14.1.5.1. Company Details

                14.1.5.2. Company Description

                14.1.5.3. Business Overview

                14.1.5.4. SWOT Analysis

                14.1.5.5. Strategic Overview

    List of Tables

    Table 01: Global Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

    Table 02: Global Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 03: Global Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by Region, 2018–2030

    Table 04: U.S. Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

    Table 05: U.S. Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 06: Europe Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

    Table 07: Europe Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

    Table 08: Europe Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 09: Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2018–2030

    Table 10: Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

    Table 11: Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 12: Japan Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

    Table 13: Japan Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 14: Rest of World Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

    Table 15: Rest of World Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    List of Figures

    Figure 01: Global Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast, 2018–2030

    Figure 02: Global Cardiovascular Proximal Anastomosis Devices Market Value Share, by Product Type, 2020

    Figure 03: Global Cardiovascular Proximal Anastomosis Devices Market Value Share, by End-user, 2020

    Figure 04: Global Cardiovascular Proximal Anastomosis Devices Market Value Share, by Region, 2020

    Figure 05: Global Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 06: Global Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by Product Type, 2020–2030

    Figure 07: Global Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn), by Automatic Proximal Anastomotic Devices, 2018–2030

    Figure 08: Global Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn), by Manual Proximal Anastomotic Devices, 2018–2030

    Figure 09: Global Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 10: Global Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by End-user, 2020–2030

    Figure 11: Global Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn), by Hospitals, 2018–2030

    Figure 12: Global Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn), by Ambulatory Surgical Centers, 2018–2030

    Figure 13: Global Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn), by Specialty Clinics, 2018–2030

    Figure 14: Global Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by Region, 2019 and 2030

    Figure 15: Global Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by Region, 2020–2030

    Figure 16: U.S. Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 17: U.S. Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 18: U.S. Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by Product Type, 2019–2030

    Figure 19: U.S. Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 20: U.S. Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by End-user, 2019–2030

    Figure 21: Europe Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 22: Europe Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

    Figure 23: Europe Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

    Figure 24: Europe Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 25: Europe Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by Product Type, 2019–2030

    Figure 26: Europe Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 27: Europe Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by End-user, 2019–2030

    Figure 28: Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 29: Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by Country/Sub-Region, 2019 and 2030

    Figure 30: Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by Country/Sub-Region, 2019–2030

    Figure 31: Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 32: Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by Product Type, 2019–2030

    Figure 33: Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 34: Middle East & Africa Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by End-user, 2019–2030

    Figure 35: Japan Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 36: Japan Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 37: Japan Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by Product Type, 2019–2030

    Figure 38: Japan Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 39: Japan Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by End-user, 2019–2030

    Figure 40: Rest of World Cardiovascular Proximal Anastomosis Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 41: Rest of World Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by Product Type, 2019 and 2030

    Figure 42: Rest of World Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by Product Type, 2019–2030

    Figure 43: Rest of World Cardiovascular Proximal Anastomosis Devices Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 44: Rest of World Cardiovascular Proximal Anastomosis Devices Market Attractiveness Analysis, by End-user, 2019–2030

Copyright © Transparency Market Research, Inc. All Rights reserved

Cardiovascular Proximal Anastomosis Devices Market

Schedule a Call